知行图书馆

Share of AI in drug discovery investors worldwide by region 2023

Published by
Matej Mikulic,
Dec 13, 2023
As of Q1 2023, there were approximately 1,900 investors involved in drug discovery with artificial intelligence (AI). More than 55 percent of all these companies originated from the United States. The European Union was ranked second with around 12 percent of these investors located within its member states.

Distribution of investors involved in AI in drug discovery worldwide as of 2023, by region

CharacteristicDistribution of investors
United States 55.2%
European Union 12.2%
Asia 9.2%
United Kingdom 7.9%
China 7.6%
Canada 3.8%
Middle East 2.3%
Australia 0.9%
Showing entries 1 to 8 (8 entries in total)
Created with Highcharts 7.2.2Distribution of investors55.2%55.2%12.2%12.2%9.2%9.2%7.9%7.9%7.6%7.6%3.8%3.8%2.3%2.3%0.9%0.9%United StatesEuropean UnionAsiaUnited KingdomChinaCanadaMiddle EastAustralia
0%2.5%5%7.5%10%12.5%15%17.5%20%22.5%25%27.5%30%32.5%35%37.5%40%42.5%45%47.5%50%52.5%55%57.5%60%62.5%

Details: Worldwide; as of Q1 2023

© Statista 2025
Download
Source

Deep Knowledge Group (Deep Pharma Intelligence)

Survey by

Deep Knowledge Group (Deep Pharma Intelligence)

Survey name

Artificial Intelligence for Drug Discovery Landscape Overview Q1 2023

Published by

Deep Knowledge Group (Deep Pharma Intelligence)

Source link

deep-pharma.tech

Release date

2023

Citation formats

Statistics on " AI in the pharmaceutical industry "

Other statistics that may interest you AI in the pharmaceutical industry

Health & pharma sector in AI

6

Drug discovery overview

8

Drug discovery players

5

Scientific publications

4

Clinical trials

4

Further Content: You might find this interesting as well

Topics

AI in pharmaceutical industryGlobal pharmaceutical industryOutsourcing in the pharmaceutical industryBiotech drugsPharmaceutical research and development (R&D)
Learn more about how Statista can support your business.